Tevogen Bio Holdings Inc.
TVGN
$6.97
-$0.03-0.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 28.24% | -4.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.53% | 5.23% | |||
| Operating Income | 19.53% | -5.23% | |||
| Income Before Tax | 18.32% | -4.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.32% | -4.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.32% | -4.05% | |||
| EBIT | 19.53% | -5.23% | |||
| EBITDA | 20.54% | -7.02% | |||
| EPS Basic | -56.86% | 2.29% | |||
| Normalized Basic EPS | -55.91% | 2.18% | |||
| EPS Diluted | -56.86% | 2.29% | |||
| Normalized Diluted EPS | -55.91% | 2.18% | |||
| Average Basic Shares Outstanding | -47.61% | 6.36% | |||
| Average Diluted Shares Outstanding | -47.61% | 6.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||